SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.28 CNY | -0.46% |
|
-2.13% | -16.43% |
| 2023 | Yiling Pharmaceutical Gets Nod for China Clinical Trial of Tracheobronchitis Drug | MT |
| 2023 | Yiling Pharmaceutical's Lianhua Qingke Tablets Gets Nod to Become Over-the-Counter Drug; Shares Up 4% | MT |
Evolution of the average Target Price on Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
1262744151f90.zA3fYWoc6y4ICpDnJ8D4XsJq179n28mLsb8-AFRT2Fs.mjS-EC1u3WdLJ9GFEbbJDKQGp9gDkpry8oxZMjc3qTm2eIhZJS2ORWdm9w~d09a2c0a56c8185e383cf94225bb779e
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
19.28
CNY
Average target price
27.02
CNY
Spread / Average Target
+40.16%
High Price Target
32.75
CNY
Spread / Highest target
+69.87%
Low Price Target
20
CNY
Spread / Lowest Target
+3.73%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 002603 Stock
- Consensus Shijiazhuang Yiling Pharmaceutical Co., Ltd.
